Journal of Innovation in Cardiac Rhythm Management
banner AtriCure sts2023

 

Activity Description
This CME-accredited enduring on-demand webcast of a satellite symposium held at the STS 59th Annual Meeting, features leading thought leaders in the field who evaluate if surgical success in managing Atrial Fibrillation is supported through evidence, or if existing barriers to its expanded application in daily clinical practice are justifiable.

 

Access Webcast

 

tmb Atricure STS2023 Panel  

Viewing Options:
Click on the presentation titles below to view individual segments of the activity, or the Access Button to view the activity in its entirety.

CME/CE Credit:
To earn credit, participants must access the Obtain Credit tab, and successfully complete the post-activity CME test.

Agenda

Barriers in Surgical Treatment of Atrial Fibrillation: A Myth or Evidence Based?
Niv Ad, MD

Surgical Ablation for AF During CABG
Stephen Waterford, MD

Multi-Valve Disease and Atrial Fibrillation
HelenMari Merritt-Genore, DO

Surgical Ablation of Atrial Fibrillation During Mitral Valve Surgery: The CTSN Trial
Marc Gillinov, MD

Commercial Support
This activity is supported through educational grant from AtriCure

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

 

Faculty

Program Director
Niv Ad MD

Niv Ad, MD
Johns Hopkins University
Silver Spring, MD

 

    

 

Faculty

Marc Gillinov MD

Marc Gillinov, MD
Cleveland Clinic
Cleveland, OH

   Stephen Waterford MD

Stephen Waterford, MD 
UPMC Health System
Erie, PA
HelenMari Merritt DO

HelenMari Merritt-Genore, DO
Nebraska Methodist Hospital
Omaha, NE

    

 

 

 

CME Accreditation

CME Released: 1/24/2023; Valid for credit through 1/24/2024

CME Certificate Fulfillment

To successfully earn credit, participants must complete the activity online during the valid credit period that is noted above. To receive AMA PRA Category 1 Credit™ or Contact Hours,you must receive a minimum score of 75% on the post-test, accessible at Obtain Credit page. CME/CE certificates are issued to your inbox upon successful completion.

Target Audience
This activity has been developed to meet the educational needs of thoracic and cardiothoracic surgeons, associated professionals, and other members of the surgical care team. 

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Discuss barriers in surgical treatment of Atrial Fibrillation, and distinguish myths from evidence based.
  • Review optimal clinical decision-making strategies and procedural approaches for the treatment of coronary artery disease and AF, and multi-valve disease and AF.
  • Examine the results and impact on daily practice of the Mitral Valve CTS trial.

Activity Goal
This activity is designed to address the following core and team competencies:
Patient care, medical knowledge, practice-based learning and improvement, interprofessional collaboration, and roles and responsibilities.

Accreditation Statement
Jointly Accredited Provider TMTo support the improvement of patient care, this activity has been planned and implemented by MediaSphere Medical and Ciné-Med. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health-care team.

Ciné-Med designates this educational activity for a maximum of 1 AMA PRA CATEGORY 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 1 Contact Hours for nurses.

Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements concerning industry support of continuing medical education. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. Speakers will disclose any relationships at the beginning of their presentations.
All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

Commercial Support
This activity is supported through educational grant from AtriCure

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

 

Obtain Credit

CME/CE Test
  1. Are Existing Barriers to the Application of Surgical Treatment of Atrial Fibrillation Justified?
    Examining the Evidence and Demystifying Myths
  2. Please complete the following CME/CE post-test. Your submission will be reviewed and notification provided shortly regarding certificate fulfillment status. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Confirm Your Email: *  
    Invalid Input
  7. Degree: *  
    Invalid Input
  8. Specialty:*  
    Invalid Input
  9. Institution: *  
    Invalid Input
  10. Mailing Address:*  
    Invalid Input
  11. City: *  
    Invalid Input
  12. State: *  
    Invalid Input

  13. 1) Which behavioral barriers are factors that prevent the treatment of AF during cardiac surgery?
  14. Select one*  




    Invalid Input Please Select one

  15. 2) What are key considerations during CABG in patient with AF?
  16. Select one*  






    Invalid Input Please Select one

  17. 3) The results from the trial evaluating Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery concluded that ablation is safe and effective, and bi-atrial maze is far superior to PVI in mitral valve patients with AF?
  18. Select one*  


    Invalid Input Please Select one

  19. 4) The results from the trial evaluating Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery concluded that ablation significantly increased 1-year freedom from AF (63% vs 29%), and ablation did not increase mortality or major adverse cardiac or cerebrovascular events?
  20. Select one*  


    Invalid Input Please Select one

  21. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  22. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  23. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  24. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  25. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  26. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  27. Discuss barriers in surgical treatment of Atrial Fibrillation, and distinguish myths from evidence based.
    Invalid Input Please Select one

  28. Review optimal clinical decision-making strategies and procedural approaches for the treatment of coronary artery disease and AF, and multi-valve disease and AF.
    Invalid Input Please Select one

  29. Examine the results and impact on daily practice of the Mitral Valve CTS trial.
    Invalid Input Please Select one

  30. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  31. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  32. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  33. Enhanced my current knowledge base:
    Invalid Input Please Select one

  34. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  35. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  36. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  37. Addressed a professional practice gap:
    Invalid Input Please Select one

  38. Was free of commercial bias/influence:
    Invalid Input Please Select one

  39. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  40. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  41. (*) Required Fields
  42. Invalid Input

Editorial Board | Author Guidelines | About Us | Contact Us | Submit Manuscript | Subscribe | Terms of Use | Privacy Policy

505 South Lenola Road, Suite 121, Moorestown, NJ 08057

  Copyright © 2011-2024  MediaSphere Medical LLC.  All Rights Reserved.   

Website Design Internet Marketing by DigitalSequence